You have read all your free articles, to continue reading subscribe to read the rest of this content.
Nanoform has announced that Proof of Concept studies will be funded by the Bill & Melinda Gates Foundation. The funding will be used to assess the added value Nanoform’s CESS nanoparticle engineering technology can deliver to several of its drug development projects. “Our goal is to imAlready a subscriber Login…
Oncopeptides has decided to reduce the activity level in the clinical development program with melflufen (INN melphalan flufenamide) to increase the company's cash runway and at the same time support the ongoing marketing authorization application process in Europe. This will have implications onAlready a subscriber Login You have read all…
The board of directors of Lytix Biopharma has decided to apply for a listing of the company on Euronext Growth, simultaneously carrying out a capital increase. Lytix Biopharma has decided to initiate the process to secure funding of the company’s development program, including phase II clinicalAlready a subscriber Login You…
The company has received Advanced Therapy Medicinal Product (ATMP) classification from the European Medicines Agency (EMA) for the company’s lead cancer relapse vaccine candidate, DCP-001. DCP-001 is derived from Immunicum’s human DCOne cell line and is currently being evaluated as a cancer rAlready a subscriber Login You have read all…
